BioCentury
ARTICLE | Clinical News

Triheptanoin: Ph II data

March 24, 2017 8:15 PM UTC

Top-line data from a double-blind, international Phase II trial in 36 patients with seizures associated with glucose transporter type-1 deficiency syndrome showed that oral triheptanoin given 4 times ...

BCIQ Company Profiles

Ultragenyx Pharmaceutical Inc.